Abstract
In the recent decades, numerous drug delivery systems based on nanoparticles have been developed. To deliver drugs to a specific site, many vehicles have been designed, including liposomes, lipid and polymeric nanoparticles. However these systems can suffer some limitations such as thermal and physical instability as well as opsonization by reticuloendothelial system. This chapter addresses the development and application of silica gel nanoparticles (nanogels) for drug delivery. The synthesis of nanoparticles by sol–gel technology offers new possibilities and many advantages for embedding organic compounds within silica, controlling their release from the host matrix into a surrounding medium, being a great potential for a variety of drug delivery applications, such as the site-specific delivery and intracellular controlled release of drugs, genes, and other therapeutic agents.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahola M, Kortesuo P, Kangasniemi I, Kiesvaara J, Yli-Urpo A (2000) Silica xerogel carrier material for controlled release of toremifene citrate. Int J Pharm 195(12):219–227
Ahola M, Saeilynoja E, Salonen J, Penttinen R, Yli-Urpo A (2001) Novel compositions for controlled release of biologically active, and the preparation thereof. World Patent No. 01 /13294
Albarrana L, Lópeza T, Quintanac P, Chagoya V (2011) Controlled release of IFC-305 encapsulated in silica nanoparticles for liver cancer synthesized by sol–gel. Colloid Surface Physicochem Eng Aspect 384(1–3):131–136
Andrade JD, Hlady V, Jeon SI (1996) Poly (ethylene oxide) and protein resistance: principles, problems, and possibilities. Adv Chem Ser 248:51–59
Anglin EJ, Cheng L, Freeman WR, Sailor MJ (2008) Porous silicon in drug delivery devices and materials. Adv Drug Deliv Rev 60(11):1266–1277
Barbe C, Bartlett J (2008) Controlled release ceramic particles, compositions thereof, process of preparation and methods of use. United States Patent No. 2008/0274199 A1
Barbe C, Bartlett J, Kong LG, Finnie K, Lin HQ, Larkin M, Calleja S, Bush A, Calleja G (2004) Silica particles: a novel drug-delivery system. Adv Mater 16(21):1959–1966
Bawa R (2007) Patents and nanomedicine. Nanomedicine 2(3):351–374
Bawa R (2009) Nanopharmaceuticals. In: Luscombe D, Stonier PD (eds) Clinical research manual supplement 27, 2nd edn. Euromed Communications, England
Bawa R, Melethil S, Simmons WJ, Harris D (2008) Nanopharmaceuticals: patenting issues and FDA regulatory challenges. The SciTech Lawyer 5(2):10–15
Bhatia RB, Brinker CJ, Gupta AK, Singh AK (2000) Aqueous Sol–gel process for protein encapsulation. Chem Mater 12:2434–2441
Brannon-Peppas L, Birnbaum DT, Kosmala JD (1997) Polymers in controlled release: targeted delivery. Polymer News 22:316–318
Buckley AM, Greenblatt M (1994) The sol gel preparation of silica gels. J Chem Educ 71:599–602
Cauda V, Engelke H, Sauer A, Arcizet D, Brauchle C, Radler J, Bein T (2010) Colchicine-loaded lipid bilayer-coated 50 nm mesoporous nanoparticles efficiently induce microtubule depolymerization upon cell uptake. Nano Lett 10:2484–2492
Costache MC, Qu H, Ducheyne P, Devore DI (2011) Polymer-xerogel composites for controlled release wound dressings. Biomaterials 31(24):6336–6343
Dahan A, Hoffman A (2008) Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs. J Control Rel 129(1):1–10
Deng Z, Zhen Z, Xiaoxi Hu X, Wu S, Xu Z, Chu PK (2011) Hollow chitosan silica nanospheres as pH-sensitive targeted delivery carriers in breast cancer therapy. Biomaterials 32(21):4976–86
Depan D, Saikia L, Singh RP (2010) Ultrasound-triggered release of ibuprofen from a chitosan-mesoporous silica composite—a novel approach for controlled drug release. Macromol Symp 287(1):80–88
Discher DE, Eisenberg A (2002) Polymer vesicles. Science 297:967–973
Du H, Hamilton PD, Reilly MA, D’Avignon A, Biswas P, Ravi N (2009) A facile synthesis of highly water-soluble, core–shell organo-silica nanoparticles with controllable size via sol–gel process. J Colloid Interface Sci 340:202–208
Ducheyne P, Cheyne P, Heyne P, Radin S, Santos EM (1996) Incorporation of biologically active molecules into bioactive glasses. World Patent No. 96/03117
Dwivedi N, Arunagirinathan MA, Sharma S, Bellare J (2010) Silica-coated liposomes for insulin delivery. J Nanomater 1–8
Fay F, Scott CJ (2011) Antibody-targeted nanoparticles for cancer therapy. Immunotherapy 3(3):381–394
Gill I, Ballesteros A (2000) Bioencapsulation within synthetic polymers (Part 1): sol–gel encapsulated biologicals. TIBTECH 18:282–296
Gregoriades G (1989) Liposomes as drug carriers. Wiley, Chichester
Hervé K, Douziech-Eyrolles KL, Munnier E, Cohen-Jonathan S, Soucé M, Marchais H, Limelette P, Warmont F, Saboungi ML, Dobois P, Chourpa I (2008) The development of stable aqueous suspensions of PEGylated SPIONs for biomedical applications. Nanotechnol 19(46):1
Horst B, Oberningenie OK, Joerg M (1995) Metal oxide composite with controllable release. European Patent No. 0 680 753 A2
Hwang YJ, Oh C, Oh SG (2005) Controlled release of retinol from silica particles prepared in O/W/O emulsion: The effects of surfactants and polymers. J Control Release 106(3):339–349
Iller RK (1979) The chemistry of silica. Wiley, New York
Illum L, Davis SS, Müller RH, Mak E, West P (1987) The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer—poloxamine 908. Life Sci 40:367–374
Iwanaga K, Ono S, Narioka K, Morimoto K, Kakemi M, Yamashita S, Nango M, Oku N (1997) Oral delivery of insulin by using surface coating liposomes: improvement of stability of insulin in GI tract. Int J Pharm 157:73–80
Iwer B, Holger E, Joern P, Miranda RG (2011) Silica sol material having at least one therapeutically active substance for producing biological degradable and/or resorbable silica gel materials for human medicine and/or medical technology. European Patent No. 2303948 (A1)
Jafarzadeh M, Rahman IA, Sipaut CS (2009) Synthesis of silica nanoparticles by modified sol–gel process: the effect of mixing modes of the reactants and drying techniques. J Sol–gel Sci Technol 50:328–336
Jokinen M, Viitala R, Jalonen H (2005) Method for preparing adjustable bioresorbable sol–gel derived SiO2. World Patent No.2005082781
Jokinen M, Jalonen H, Forsback A, Koskinen M (2010) Method for preparing silica compositions and uses thereof. United States Patent No.2010/0119500
Jung T, Kamm W, Breitenbach A, Kaiserling E, Xiao JX, Kissel T (2000) Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? Eur J Pharm Biopharm 50(1):147–160
Karajgi J, Jain NK, Vyas SP (1993) Passive vectoring of a colloidal carrier system for sodium stibogluconate: preparation, characterization and performance evaluation. J Drug Target 3:197–206
Kesisoglou F, Panmai S, Wu Y (2007) Nanosizing-oral formulation development and biopharmaceutical evaluation. Adv Drug Del Rev 59:631–644
Kisel MA, Kulik LN, Tsybovsky IS, Vlasov AP, Vorob’yov MS, Kholodova EA, Zabarovskaya ZV (2001) Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat. Int J Pharm 216:105–114
Kortesuo P, Ahola M, Kangas M, Yli-Urpo A, Kiesvaara J, Marvola M (2001) In vitro release of dexmedetomidine from silica xerogel monoliths: effect of sol–gel synthesis parameters. Inter J Phar 221:107–114
Kortesuo P, Ahola M, Minna K, Mika J, Tiina L, Lauri V et al (2002) Effect of synthesis parameters of the sol–gel-processed spray-dried silica gel microparticles on the release rate of dexmedetomidine. Biomaterials 23(13):2795–2801
Koskinen M, Saeilynoja E, Ahola M, Jalonen H, Salonen J, Kaehaeri V (2001) Biodegradable carrier and method for preparation thereof. World Patent No. 02080977
Kunarti ES, Moran GM (2008) Entrapment of avidin in sol–gel derived silica glasses. J Phys Sci 19(2):31–44
Lapidot N, Magdassi S, Avnir D, Rottman C, Gans O, Seri-Levy A (2001) Sunscreen composition containing sol–gel microcapsules. United States Patent No. 6,238,650
Lapidot N, Magdassi S, Avnir D, Rottman C, Gans O, Seri-Levy A (2010) Composition exhibiting enhanced formulation stability and delivery of topical active ingredients. United States Patent No. 60/198,749
Lee S-M, Chen H, Dettmer CM, O’Halloran TV, Nguyen ST (2007) Polymer-caged lipsomes: a pH-responsive delivery system with high stability. J Am Chem Soc 129:15096–15097
Li X, Ding L, Xu Y, Wang Y, Ping Q (2009) Targeted delivery of doxorubicin using stealth liposomes modified with transferrin. Int J Pharm 373:116–123
Lincopan N, Santana MRA, Faquim-Mauro E, da Costa MHB, Carmona-Ribeiro AM (2009) Silica-based cationic bilayers as immunoadjuvants. BMC Biotechnol 9:5. doi:10.1186/1472-6750-9-5
Martens J, Van Den Mooter G, Van Humbeeck J, Mellaerts R (2007) Controlled release delivery system for bio-active agents. United States Patent No. 2007/0275068 A1
Martini A, Ciocca C (2003) Drug delivery systems for cancer drugs. Expert Opin Ther Pat 13(12):1801–1807
Mohanraj VJ, Barnes TJ, Prestidge CA (2010) Silica nanoparticles coated liposomes: a new type of hybrid nanocapsule for proteins. Int J Pharm 392(1–2):285–293
Nishihama S (2001) Metal oxide/silica composite, and a cosmetic preparation comprising thereof. United States Patent No. 6,949,248
Perro A, Reculusa S, Bourgeat-Lami E, Duguet E, Ravaine S (2006) Synthesis of hybrid colloidal particles: from snowman-like to raspberry-like morphologies. Colloid Surf A 284(285):78–83
Porter CJH, Pouton CW, Cuine JF, Charman WN (2008) Enhancing intestinal drug solubilization using lipid -based delivery systems. Adv Drug Delivery Rev 60(6):673–691
Prokopowicz M (2009) Correlation between physicochemical properties of doxorubicin-loaded silica/polydimethylsiloxane xerogel and in vitro release of drug. Acta Biomaterials 5:193–207
Prokopowicz M, Łukasiak J (2010) Synthesis and in vitro characterization of freeze-dried doxorubicin-loaded silica/PEG composite. J Non-Crystall Sol 356:1711–1720
Radin S, Ducheyne P, Kamplain T, Tan BH (2001) Silica sol–gel for the controlled release of antibiotics. I. Synthesis, characterization, and in vitro release. J Biomed Mater Res 57(2):313–320
Rahman IA, Vejayakumaran P, Sipaut CS, Ismail J, Abu Bakar M, Adnan R, Chee CK (2004) An optimized sol–gel synthesis of stable primary equivalent silica particles. Colloid Surface Physicochem Eng Aspect 294:102–110
Rio-Echevarria IM, Selvestrel F, Daniela Segat D, Guarino G, Tavano R, Causin V, Reddi E, Papini E, Mancin F (2010) Highly PEGylated silica nanoparticles: “ready to use” stealth functional nanocarriers. J Mater Chem 20:2780–2787
Ritger PL, Peppas N (1987) Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres cylinders or discs. J Control Release 5:23–36
Rosen M (1989) Surfactants and interfacial phenomena, 2nd edn. Wiley, New York
Rosen H, Abribat T (2005) The rise of drug delivery. Nat Rev Drug Discov 4:381–385
Ryan SM, Mantovani G, Wang XX, Haddleton DM, Brayden DJ (2008) Advances in PEGylation of important biotech molecules: delivery aspects. Expert Opin Drug Deliv 5(4):371–383
Sato S, Murakata T, Suzuki T, Ohgawara T (1990) Control of pore size distribution of silica gel through sol–gel process using water soluble polymers as additives. J Mater Sci 254:4880–4885
Seop KG, Geun LY, Chang YY (2001) Powder color cosmetic containing pigment coated with silica. Patent No. KR 20010057526
Shi ZG, Guo QZ, Liu YT, Xiao YX, Xu L (2011) Drug delivery devices based on macroporous silica spheres. Mater Chem Phys 126(3):826–831
Silva CS, Airoldi C (1997) Acid and base catalysts in the hybrid silica sol–gel process. J Colloidal Interface Sci 195:381–387
Simovic S, Heard P, Hui H, Song Y, Peddie F, Davey AK, Lewis A, Rades T, Prestidge CA (2009) Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs. Mol Pharm 6(3):861–872
Singh KP, Panwar P, Kohli P (2011) Liposome-mesoporous silica nanoparticles fused cores: a safer mode of drug carrier. J Biomed Nanotechnol 7(1):60–62, 63
Tan BH, Santos EM, Ducheyne P (1996) Ultramicroscopic pore size and porosity of xerogels for controlled release of biological molecules. Fifth World Biomaterials Congress, Toronto
Tan A, Simovic S, Davey AK, Rades T, Prestidge CA (2009) Silica-lipid hybrid (SLH) microcapsules: a novel oral delivery system for poorly soluble drugs. J Control Release 134(1):62–70
Teng Z, Han Y, Li J, Yan F, Yang W (2010) Preparation of hollow mesoporous silica spheres by a sol–gel/emulsion approach. Micro Meso Mater 127:67–72
Traynor DH, Taynor HG, Markowitz SM, Compton DL (2005) Bodywash additives. United States Patent No. 60/648,961
Unger K, Rupprecht H, Valentin B, Kircher W (1983) The use of porous and surface modified silicas as drug delivery and stabilizing agent. Drug Dev Ind Pharm 9:69–91
Wang J, Yang X (2008) Raspberry-like polymer/silica core-corona composite by self-assemble heterocoagulation based on a hydrogen-bonding interaction. Colloid Polym Sci 286:283–291
Wu Z, Joo H, Lee TG, Lee K (2005) Controlled release of lidocaine hydrochloride from the surfactant-doped hybrid xerogels. J Control Release 104:497–505
Yagüe C, Morosa M, Grazúa V, Arruebo M, Santamaría J (2008) Synthesis and stealthing study of bare and PEGylated silica micro- and nanoparticles as potential drug-delivery vectors. Chem Eng J 137(1):45–53
Yan E, Fu Y, Wang X, Ding Y, Qian H, Wang C, Hu Y, Jiang X (2011) Hollow chitosan–silica nanospheres for doxorubicin delivery to cancer cells with enhanced antitumor effect in vivo. J Mater Chem 21:3147
Yogeshkumar M, Marilena L, Seifalian AM (2009) Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol Sci 30(11):592–599
Yuichi T, Eri S, Hirofumi T (2010) Release profile of insulin entrapped on mesoporous materials by freeze–thaw method. Inter J of Pharm 386:172–177
Zhang K, Chen HT, Chen X, Chen ZM, Cui ZC, Yang B (2003) Monodisperse silica-polymer core-shell microspheres via surface grafting and emulsion polymerization. Macromol Mater Eng 288:380–385
Zhang C, Hou TA, Chen JF, Wen LX (2010) Preparation of mesoporous silica microspheres with multi-hollow cores and their application in sustained drug release. Particuology 8(5):447–452
Acknowledgments
The authors would like to acknowledge the Portuguese Science and Technology Foundation (FCT) under the reference PTDC/SAU-FAR/113100/2009. Ana Luiza R. de Souza was sponsored by CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior). Tatiana Andreani was sponsored by FCT (SFRH/BD/60640/2009).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Andreani, T., de Souza, A.L.R., Silva, A.M., Souto, E.B. (2012). Sol–Gel Carrier System: A Novel Controlled Drug Delivery. In: Souto, E. (eds) Patenting Nanomedicines. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-29265-1_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-29265-1_5
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-29264-4
Online ISBN: 978-3-642-29265-1
eBook Packages: Humanities, Social Sciences and LawLaw and Criminology (R0)